MSL Talk
MSL Talk, hosted by Tom Caravela, MSL Recruiter and Founder of The Carolan Group, offers insights for Medical Science Liaisons, aspiring MSLs, and Medical Affairs leaders.
MSL vs. MOL - ALL You Need to Know
In this episode, Tom Caravela is joined by Mahesh Tawney to explore the evolving role of Medical Outcomes Liaisons (MOLs). They delve into the distinctions between MSL and MOL positions, highlighting the unique value narrative MOLs bring to the table. The discussion covers collaboration with market access and reimbursement specialists, as well as the metrics used to gauge MOL success. Tom and Mahesh emphasize effective communication strategies and the importance of both IQ and EQ in liaison roles. The conversation also touches on the collaborative mindset necessary for MSLs, strategies for transitioning from MSL to MOL, and networking. The episode concludes with insights into the future of MOL roles.
Key Points
- Medical outcomes liaisons (MOLs) focus on translating clinical fluency into value narratives for payers and health system stakeholders, distinct from the deep scientific exchange roles of medical science liaisons (MSLs).
- Key success metrics for MOLs include ensuring clean access to drugs, reversing restrictive medical policies, and fostering strong relationships with payers and IDN stakeholders.
- The demand for MOLs is expected to grow as the healthcare landscape shifts towards value-based care and the increasing prevalence of high-cost specialty pharmacy drugs.
Chapters
| 0:00 | |
| 1:13 | |
| 2:01 | |
| 3:26 | |
| 7:28 | |
| 10:22 | |
| 11:00 | |
| 17:17 | |
| 19:11 | |
| 20:56 | |
| 21:44 | |
| 27:42 | |
| 31:58 | |
| 35:15 |
Transcript
Loading transcript...
- / -